Not logged in Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial Okines, Alicia F. C.; Curigliano, Giuseppe; Oh, Do-Youn; Rorive, Andree; Takahashi, Shunji; Burkard, Mark E.; Chung, Ki Y.; Debruyne, Philip R.; Fox, Jenny R.; Gambardella, Valentina; Gil-Martin, Marta; Hamilton, Erika P.; Monk, Bradley J.; Nakamura, Yoshiaki; O'Malley, David M.; Olawaiye, Alexander B.; Pothuri, Bhavana; Reck, Martin; Sudo, Kazuki; Sunakawa, Yu; Van Marcke, Cedric; Yu, Evan Y.; Ramos, Jorge; Tan, Sherry; Bieda, Mark; Stinchcombe, Thomas E.; Pohlmann, Paula R. Share Save
Tucatinib and Trastuzumab for Patients With Previously Treated, HER2-Altered Solid Tumors (SGNTUC-019): A Phase 2 Basket Study Nakamura, Y.; Bekaii-Saab, T.; Hamilton, E.; Hayashi, H.; Mizuno, N.; Monk, B. J.; Nguyen, D.; Okines, A.; O'Malley, D. M.; Pohlmann, P. R.; Pothuri, B.; Reck, M.; Sudo, K.; Sunakawa, Y.; Takahashi, S.; Yu, E. Y.; Drees, A.; Tan, S.; Stinchcombe, T. E. Share Save
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study Coriano, Matilde; Tommasi, Chiara; Dinh, Anh Thi Lan; Needham, Jazmine; Aziz, Hala; Joharatnam-Hogan, Nalinie; Cunningham, Niamh; Waterhouse, Jasmin; Sun, Mingze; Turkes, Fiona; Pellegrino, Benedetta; Mcgrath, Sophie; Okines, Alicia; Parton, Marina; Turner, Nicholas; Johnston, Stephen; Musolino, Antonino; Ring, Alistair; Battisti, Nicolo Matteo Luca Share Save
HER2CLIMB-02: Randomized, Double-Blind Phase 3 Trial of Tucatinib and Trastuzumab Emtansine for Previously Treated HER2-Positive Metastatic Breast Cancer Hurvitz, Sara; Loi, Sherene; O'Shaughnessy, Joyce; Okines, Alicia; Tolaney, Sara; Sohn, Joo Hyuk; Saura, Cristina; Zhu, Xiaofu; Cameron, David; Bachelot, Thomas; Hamilton, Erika; Curigliano, Giuseppe; Wolff, Antonio; Harbeck, Nadia; Masuda, Norikazu; Vahdat, Linda; Zaman, Khalil; Valdes-Albini, Frances; Block, Margaret; Pluard, Timothy; Tan, Tira; Gawryletz, Chelsea; Chan, Arlene; Bedard, Philippe; Yerushalmi, Rinat; Xu, Binghe; Tryfonidis, Konstantinos; Schmitt, Michael; Xie, Joan; Borges, Virginia Share Save
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom Hanna, Daire; Merrick, Sophie; Ghose, Aruni; Devlin, Michael John; Yang, Dorothy D.; Phillips, Edward; Okines, Alicia; Chopra, Neha; Papadimatraki, Elisavet; Ross, Kirsty; Macpherson, Iain; Boh, Zhuang Y.; Michie, Caroline O.; Swampillai, Angela; Gupta, Sunnia; Robinson, Tim; Germain, Lewis; Twelves, Chris; Atkinson, Charlotte; Konstantis, Apostolos; Riddle, Pippa; Cresti, Nicola; Naik, Jay D.; Borley, Annabel; Guppy, Amy; Schmid, Peter; Phillips, Melissa Share Save
Tracking triple negative breast cancer (TNBC) evolution in the molecular residual disease (MRD) setting in the c-TRAK TN clinical trial Coakley, Maria; Cutts, Rosalind J.; Sritharan, Prithika; Hrebien, Sarah; Swift, Claire; Dunne, Kathryn; Kilburn, Lucy; Goddard, Katie; Villacampa, Guillermo; Rojas, Patricia; Emmett, Warren; Pipinikas, Christodoulos; Hall, Peter; Harper-Wynne, Catherine; Hickish, Tamas; Macpherson, Iain; Okines, Alicia; Wardley, Andrew; Wheatley, Duncan; Waters, Simon; Bliss, Judith M.; Garcia-Murillas, Isaac; Turner, Nicholas C. Share Save
Expert UK consensus on the definition of high risk of recurrence in HER2-negative early breast cancer: A modified Delphi panel Copson, E. R.; Abraham, J. E.; Braybrooke, J. P.; Cameron, D.; Mcintosh, S. A.; Michie, C. O.; Okines, A. F. C.; Palmieri, C.; Raja, F.; Roylance, R. Share Save
Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2D metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis (vol 33, pg 321, 2022) Curigliano, G.; Mueller, V.; Borges, V.; Hamilton, E.; Hurvitz, S.; Loi, S.; Murthy, R.; Okines, A.; Paplomata, E.; Cameron, D.; Carey, L. A.; Gelmon, K.; Hortobagyi, G. N.; Krop, I.; Loibl, S.; Pegram, M.; Slamon, D.; Ramos, J.; Feng, W.; Winer, E. Share Save
A randomised phase II trial of palbociclib and fulvestrant vs standard endocrine therapy in patients with ER positive HER2 negative breast cancer and ctDNA detected molecular relapse during adjuvant endocrine therapy (TRAK-ER) Turner, Nicholas; Phillips, Edward R.; Bunce, Catey; Robert, Marie; Bailleux, Caroline; Garcia-Murillas, Isaac; Khabra, Komel; Macpherson, Iain; O'Brien, Ciara S.; Okines, Alicia F.; Palmieri, Carlo; Schmid, Peter; Swift, Claire; Yara, Sabrina; Connolly, Simon; Lemonnier, Jerome; Lee, Dymphna; Andre, Fabrice Share Save
Comparison of a personalized sequencing assay and digital PCR for circulating tumor DNA based Molecular Residual Disease detection in early-stage triple negative breast cancer in the cTRAK-TN trial Coakley, Maria; Sritharan, Prithika; Villacampa, Guillermo; Swift, Claire; Dunne, Kathryn; Kilburn, Lucy; Goddard, Katie; Rojas, Patricia; Joad, Andy; Emmett, Warren; Knape, Charlene; Howarth, Karen; Hall, Peter S.; Harper-Wynne, Catherine; Hickish, Tamas; Macpherson, Iain; Okines, Alicia F.; Wardley, Andrew M.; Wheatley, Duncan; Waters, Simon; Cutts, Rosalind; Garcia-Murillas, Isaac; Bliss, Judith; Turner, Nicholas Share Save
Share Save
Results from a dose escalation phase 1b study of palbociclib and avelumab in advanced breast cancer in the PAveMenT Trial Okines, Alicia F.; Moghadam, Houman; Sparks, Laura; Mohammed, Kabir; Dunne, Kathryn; Nerurkar, Ashutosh; Osin, Peter; Swift, Claire; Sardinha, Ruth; Turner, Nicholas Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
